General Information of Disease (ID: DISKGU59)

Disease Name Potocki-Shaffer syndrome
Synonyms Defect11 syndrome; deletion of chromosome 11p11.2; chromosome 11P11.2 deletion syndrome; PSS; proximal 11P deletion syndrome; Potocki-Shaffer syndrome; 11p11.2 deletion; proximal 11p deletion syndrome
Definition
Potocki-Shaffer syndrome is characterized by multiple exostoses, parietal foramina, enlargement of the anterior fontanelle and occasionally intellectual deficit and mild cranio-facial anomalies. To date, 23 individuals from 14 families have been reported. The syndrome is caused by contiguous gene deletions on the short arm of chromosome 11 (11p11.2).
Disease Hierarchy
DIS7667R: Multiple congenital anomalies/dysmorphic syndrome-variable intellectual disability syndrome
DIS6SVEE: Syndromic disease
DIS0N11Z: Partial deletion of the short arm of chromosome 11
DISKGU59: Potocki-Shaffer syndrome
Disease Identifiers
MONDO ID
MONDO_0011022
MESH ID
C538356
UMLS CUI
C1832588
OMIM ID
601224
MedGen ID
318657
Orphanet ID
52022
SNOMED CT ID
702346005

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 4 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
CCR8 TTE836A Strong Altered Expression [1]
IFNL1 TTM624L Strong Altered Expression [2]
BLK TTNDSC3 Definitive Genetic Variation [3]
VIPR2 TT4O5P0 Definitive Altered Expression [4]
------------------------------------------------------------------------------------
This Disease Is Related to 18 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
ALX4 OTNS9A29 Limited Genetic Variation [5]
EXT2 OT8IR5QN Limited Genetic Variation [5]
MSX2 OT1WDKE1 Disputed Biomarker [6]
CCL25 OTLWJ8CJ Strong Biomarker [7]
CDSN OTQW4HV6 Strong Genetic Variation [8]
CHST8 OTQT4TKR Strong Genetic Variation [9]
PHF21A OTU3FFG4 Strong Autosomal dominant [10]
CDC42EP1 OTT525WA Definitive Biomarker [11]
CNTRL OTQI3VBA Definitive Biomarker [11]
CST4 OTXXM8EH Definitive Altered Expression [12]
EDA OTAKS5WS Definitive Altered Expression [13]
FAM167A OT9JF3JQ Definitive Genetic Variation [3]
FCRL4 OT3DVTRV Definitive Biomarker [14]
GTF2I OTUYL1TQ Definitive Genetic Variation [15]
KLRB1 OTQ2959Y Definitive Biomarker [16]
RO60 OTLGM5A8 Definitive Genetic Variation [17]
SSB OTCCTPBR Definitive Altered Expression [18]
SSNA1 OTWARAMR Definitive Biomarker [19]
------------------------------------------------------------------------------------
⏷ Show the Full List of 18 DOT(s)

References

1 Upregulation and pathogenic roles of CCL18-CCR8 axis in IgG4-related disease.Mod Rheumatol. 2020 Jul;30(4):729-737. doi: 10.1080/14397595.2019.1632061. Epub 2019 Aug 8.
2 Increased expression of interferon- in minor salivary glands of patients with primary Sjgren's syndrome and its synergic effect with interferon- on salivary gland epithelial cells.Clin Exp Rheumatol. 2018 May-Jun;36 Suppl 112(3):31-40. Epub 2017 Apr 18.
3 Polymorphisms in the FAM167A-BLK, but not BANK1, are associated with primary Sjgren's syndrome in a Han Chinese population.Clin Exp Rheumatol. 2013 Sep-Oct;31(5):704-10. Epub 2013 Jul 30.
4 Monocytes from Sjgren's syndrome patients display increased vasoactive intestinal peptide receptor 2 expression and impaired apoptotic cell phagocytosis.Clin Exp Immunol. 2014 Sep;177(3):662-70. doi: 10.1111/cei.12378.
5 A microdeletion encompassing PHF21A in an individual with global developmental delay and craniofacial anomalies.Am J Med Genet A. 2015 Dec;167A(12):3011-8. doi: 10.1002/ajmg.a.37344. Epub 2015 Sep 3.
6 Proximal 11p deletion syndrome (P11pDS): additional evaluation of the clinical and molecular aspects.Eur J Hum Genet. 2004 May;12(5):400-6. doi: 10.1038/sj.ejhg.5201163.
7 Decreased circulating CXCR3+CCR9+T helper cells are associated with elevated levels of their ligands CXCL10 and CCL25 in the salivary gland of patients with Sjgren's syndrome to facilitate their concerted migration.Scand J Immunol. 2020 Mar;91(3):e12852. doi: 10.1111/sji.12852. Epub 2019 Dec 13.
8 Inflammatory peeling skin syndrome caused a novel mutation in CDSN.Arch Dermatol Res. 2012 Apr;304(3):251-5. doi: 10.1007/s00403-011-1195-z. Epub 2011 Dec 7.
9 Whole-exome sequencing in a single proband reveals a mutation in the CHST8 gene in autosomal recessive peeling skin syndrome. Genomics. 2012 Apr;99(4):202-8. doi: 10.1016/j.ygeno.2012.01.005. Epub 2012 Jan 25.
10 The PHF21A neurodevelopmental disorder: an evaluation of clinical data from 13 patients. Clin Dysmorphol. 2023 Apr 1;32(2):49-54. doi: 10.1097/MCD.0000000000000455. Epub 2023 Feb 21.
11 Antibodies against citrullinated alpha enolase peptides in primary Sjogren's syndrome.Clin Immunol. 2017 Oct;183:300-303. doi: 10.1016/j.clim.2017.09.012. Epub 2017 Sep 14.
12 Cystatin S-a candidate biomarker for severity of submandibular gland involvement in Sjgren's syndrome.Rheumatology (Oxford). 2017 Jun 1;56(6):1031-1038. doi: 10.1093/rheumatology/kew501.
13 X-linked ectodermal dysplasia receptor (XEDAR) gene silencing prevents caspase-3-mediated apoptosis in Sjgren's syndrome.Clin Exp Med. 2017 Feb;17(1):111-119. doi: 10.1007/s10238-015-0404-z. Epub 2015 Dec 11.
14 FcRL4(+) B-cells in salivary glands of primary Sjgren's syndrome patients.J Autoimmun. 2017 Jul;81:90-98. doi: 10.1016/j.jaut.2017.03.012. Epub 2017 Apr 6.
15 Identification of susceptibility gene associated with female primary Sjgren's syndrome in Han Chinese by genome-wide association study.Hum Genet. 2016 Nov;135(11):1287-1294. doi: 10.1007/s00439-016-1716-0. Epub 2016 Aug 8.
16 Clinical relevance of ROR positive and negative subsets of CD161+CD4+ T cells in primary Sjgren's syndrome.Rheumatology (Oxford). 2017 Feb;56(2):303-312. doi: 10.1093/rheumatology/kew360. Epub 2016 Nov 1.
17 Autoantibody repertoire to Ro/SSA and La/SSB antigens in patients with primary and secondary Sjgren's syndrome.J Autoimmun. 1996 Aug;9(4):537-44. doi: 10.1006/jaut.1996.0072.
18 Hypokalaemia in Sjgren's syndrome: the missing piece.Clin Med (Lond). 2017 Feb;17(1):40-42. doi: 10.7861/clinmedicine.17-1-40.
19 The orthologue of Sjgren's syndrome nuclear autoantigen 1 (SSNA1) in Trypanosoma brucei is an immunogenic self-assembling molecule.PLoS One. 2012;7(2):e31842. doi: 10.1371/journal.pone.0031842. Epub 2012 Feb 20.